GLP-1 and endometroid endometrial adenocarcinoma
This study will explore the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) used concurrently with levonorgestrel intrauterine device in patients with poor surgical candidacy for a hysterectomy or patients who are pursuing fertility…
- Investigator
- Kaitlin M Nicholson
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- Female
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine…
- Investigator
- Kaitlin M Nicholson
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
